A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent

A Double-blind, Placebo-controlled, Randomized, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BMS-986322 in Healthy Participants of Japanese Descent

The purpose of this study is to assess the safety and tolerability of multiple ascending oral doses of BMS-986322 in healthy participants of Japanese descent.

Inclusion Criteria:

• Participant must be of Japanese descent (both biological parents are ethnically Japanese).
• In the opinion of the investigator, is a healthy participant, without any clinically significant abnormalities in their medical history, physical examination, ECGs, or clinical laboratory assessments determinations.
• Women should be of non-childbearing potential.

Exclusion Criteria:

• Any significant acute or chronic medical illness.
• Current or recent (within 3 months of study drug administration) gastrointestinal disease that could impact upon the absorption of study drug.
• Any major surgery within 90 days of study drug administration.

Other protocol-defined inclusion/exclusion criteria apply.